Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA.
We thank Monneret and Bonnefont-Rousselot for their commentary. Our controlled trial design overcomes most of their concerns of course; any failure of assay techniques would not have produced a biased result, but in fact would have decreased the chances of finding any between-group effects. In our s...
Príomhchruthaitheoirí: | Antoniades, C, Lee, R, Kohler, M, Stradling, J |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
European Respiratory Society
2016
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Overnight urinary isoprostane levels during CPAP withdrawal as a marker of oxidative stress
de réir: Turnbull, C, et al.
Foilsithe / Cruthaithe: (2016) -
The effects of CPAP withdrawal in patients with OSA on hypoxia-induced markers
de réir: Turnbull, C, et al.
Foilsithe / Cruthaithe: (2016) -
Effect of CPAP withdrawal on myocardial perfusion in OSA - a randomized controlled trial
de réir: Schwarz, E, et al.
Foilsithe / Cruthaithe: (2016) -
Blood pressure variability in OSA – data from four randomised-controlled CPAP-withdrawal trials
de réir: Lettau, F, et al.
Foilsithe / Cruthaithe: (2017) -
Effect of CPAP-withdrawal on blood pressure in OSA: data from three randomized-controlled trials
de réir: Schwarz, E, et al.
Foilsithe / Cruthaithe: (2016)